Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - SANGAMO THERAPEUTICS, INC | Financial_Report.xls |
10-K - FORM 10-K - SANGAMO THERAPEUTICS, INC | d280209d10k.htm |
EX-31.1 - RULE 13A-14(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER - SANGAMO THERAPEUTICS, INC | d280209dex311.htm |
EX-31.2 - RULE 13A-14(A) CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - SANGAMO THERAPEUTICS, INC | d280209dex312.htm |
EX-10.57 - COLLABORATION AND LICENSE AGREEMENT - SANGAMO THERAPEUTICS, INC | d280209dex1057.htm |
EX-10.55 - AMENDED AND RESTATED EMPLOYMENT AGREEMENT - SANGAMO THERAPEUTICS, INC | d280209dex1055.htm |
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - SANGAMO THERAPEUTICS, INC | d280209dex231.htm |
Exhibit 32.1
Certification Pursuant to 18 U.S.C. §1350, as Adopted Pursuant to §906 of the Sarbanes-Oxley Act of 2002
Each of the undersigned hereby certifies pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Sangamo BioSciences, Inc. (the Company), that:
(1) the Annual Report of the Company on Form 10-K for the year ended December 31, 2011, as filed with the Securities and Exchange Commission (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Edward O. Lanphier II |
Edward O. Lanphier II |
President, Chief Executive Officer and Director |
(Principal Executive Officer) |
February 22, 2012 |
/s/ H. Ward Wolff |
H. Ward Wolff |
Executive Vice President and Chief Financial Officer |
(Principal Financial and Accounting Officer) |
February 22, 2012 |